Vaccine against Rift Valley Fever

Impact story

Vaccine against Rift Valley fever

Rift Valley fever virus (RVFV) is a mosquito-transmitted virus causing mortality among farm animals. It is one of the 8 pathogens of the World Health Organisation list of top-emerging diseases that are likely to cause major epidemics. The virus is currently circulating on the continent of Africa but is also a risk for other continents including Europe.

Vaccine development

Wageningen Bioveterinary Research developed a live-weakened vaccine that is optimally designed for safety and effectiveness. The vaccine will be further developed together with the industry to achieve effective control of Rift Valley fever.

Read more about the disease:

Read this news: